|
1
|
Tamascar I and Ramanarayanan J: Targeted
treatment of chronic myeloid leukemia: Role of imatinib. Onco
Targets Ther. 2:63–71. 2009.PubMed/NCBI
|
|
2
|
Jabbour E and Kantarjian H: Chronic
myeloid leukemia: 2016 update on diagnosis, therapy, and
monitoring. Am J Hematol. 91:252–265. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baxter EJ, Scott LM, Campbell PJ, East C,
Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N,
et al: Acquired mutation of the tyrosine kinase JAK2 in human
myeloproliferative disorders. Lancet. 365:1054–1061. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Safaei A, Shokripour M and Omidifar N:
Bone marrow and karyotype findings of patients with pancytopenia in
southern iran. Iran J Med Sci. 39:333–340. 2014.PubMed/NCBI
|
|
6
|
Onodera N, McCabe NR and Rubin CM: Rubin:
Formation of a hyperdiploid karyotype in childhood acute
lymphoblastic leukemia. Blood. 80:203–208. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Belurkar S, Manohar C and Kurien A:
Chronic myeloid leukemia with hyperdiploidy: A case report with
review of literature. Indian J Med Sci. 67:188–192. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roland B and Blahey WB: A case of
near-triploidy in chronic myelogenous leukemia. Cancer Genet
Cytogenet. 121:96–98. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yehuda O, Abeliovich D, Ben-Neriah S,
Sverdlin I, Cohen R, Varadi G, Orr R, Ashkenazi YJ, Heyd J, Lugassy
G and Ben Yehuda D: Clinical implications of fluorescence in situ
hybridization analysis in 13 chronic myeloid leukemia cases:
Ph-negative and variant Ph-positive. Cancer Genet Cytogenet.
114:100–107. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Al-Achkar W, Moassass F, Ikhtiar A, Liehr
T, Othman MA and Wafa A: Hyperdiploidy associated with T315I
mutation in BCR-ABL kinase domain in an accelerated phase-chronic
myeloid leukemia case. Mol Cytogenet. 7:892014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Paulsson K and Johansson B: High
hyperdiploid childhood acute lymphoblastic leukemia. Genes
Chromosomes Cancer. 48:637–660. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mrózek K, Harper DP and Aplan PD:
Cytogenetics and molecular genetics of acute lymphoblastic
leukemia. Hematol Oncol Clin North Am. 23991–1010. (v)2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smadja NV, Bastard C, Brigaudeau C, Leroux
D and Fruchart C; Groupe Français de Cytogénétique Hématologique, :
Hypodiploidy is a major prognostic factor in multiple myeloma.
Blood. 98:2229–2238. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Barlogie B, Alexanian R, Dixon D, Smith L,
Smallwood L and Delasalle K: Prognostic implications of tumor cell
DNA and RNA content in multiple myeloma. Blood. 66:338–341. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Latreille J, Barlogie B, Dosik G, Johnston
DA, Drewinko B and Alexanian R: Cellular DNA content as a marker of
human multiple myeloma. Blood. 55:403–408. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morgan RJ Jr, Gonchoroff NJ, Katzmann JA,
Witzig TE, Kyle RA and Greipp PR: Detection of hypodiploidy using
multi-parameter flow cytometric analysis: A prognostic indicator in
multiple myeloma. Am J Hematol. 30:195–200. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garcia-Sanz R, Orfão A, González M, Moro
MJ, Hernández JM, Ortega F, Borrego D, Carnero M, Casanova F,
Jiménez R, et al: Prognostic implications of DNA aneuploidy in 156
untreated multiple myeloma patients. Castelano-Leones (Spain)
cooperative group for the study of monoclonal gammopathies. Br J
Haematol. 90:106–112. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heerema NA, Raimondi SC, Anderson JR,
Biegel J, Camitta BM, Cooley LD, Gaynon PS, Hirsch B, Magenis RE,
McGavran L, et al: Specific extra chromosomes occur in a modal
number dependent pattern in pediatric acute lymphoblastic leukemia.
Genes Chromosomes Cancer. 46:684–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rojas A, Pineda L, González S, Soto M,
Avila E, Urdaneta B, Prieto-Carrasquero M and González R:
Chromosomal abnormalities in malignant hematologic diseases. Acta
Cient Venez. 51:109–114. 2000.(In Spanish). PubMed/NCBI
|
|
20
|
Werner M, Kaloutsi V, Buhr T, Delventhal
S, Vykoupil KF and Georgii A: Cytogenetics of chronic myelogenous
leukemia (CML) correlated to the histopathology of bone marrow
biopsies. Ann Hematol. 63:201–205. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meng CY: Cytogenetics and molecular
studies in chronic myeloid leukemiaClements University; 2001
|
|
22
|
Stagno F, Vigneri P, Consoli ML, Cupri A,
Stella S, Tambè L, Massimino M, Manzella L and Di Raimondo F:
Hyperdiploidy associated with a high BCR-ABL transcript level may
identify patients at risk of progression in chronic myeloid
leukemia. Acta Haematol. 127:7–9. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
AM B: Cancer cytogeneticsThe principles of
clinical cytogenetics. Totowa, New Jersey: Humana Press Inc;
1999
|
|
24
|
Godley LA and Le Beau MM: Williams
Hematology8. Cytogenetics and molecular abnormalities. McGraw Hill;
2008
|
|
25
|
Wang Z, Zen W, Meng F, Xin X, Luo L, Sun
H, Zhou J and Huang L: Chronic myeloid leukemia with variation of
translocation at (Ph) [ins (22;9) (q11;q21q34)]: A case report. Int
J Clin Exp Pathol. 8:13707–13710. 2015.PubMed/NCBI
|
